Advertisement

Boston Scientific CEO Michael Mahoney plans to lead the Natick medical device maker’s growth in 2013 through innovation and by integrating its recent acquisitions of BridgePoint Medical Inc. and Rhythmia Medical Inc.

Advertisement
Advertisement